While the PI3K-Akt pathway has been previously associated with physiologic cardiac hypertrophy (67–69), the newly observed association with LGE in HCM has particularly relevant clinical implications because the downstream Ras-MAPK pathway is modifiable. This evidence concerns the gene AKT1 and cardiac hypertrophy.